Controlled release systems for DNA delivery (Q35826516)

10 August 2017

1 reference

title

Controlled release systems for DNA delivery (English)

1 reference

10 August 2017

Angela K Pannier

1

1 reference

10 August 2017

Lonnie D Shea

series ordinal

2

1 reference

10 August 2017

publication date

1 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

10

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

19-26

1 reference

Enhancement of transfection by physical concentration of DNA at the cell surface

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Stabilized plasmid-lipid particles for systemic gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

DNA delivery from polymer matrices for tissue engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Development of growth factor fusion proteins for cell-triggered drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Localized adenovirus gene delivery using antiviral IgG complexation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Surface-tethered DNA complexes for enhanced gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Improving protein therapeutics with sustained-release formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Why proteins prefer interfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Biologically erodable microspheres as potential oral drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Three-dimensional cell-scaffold constructs promote efficient gene transfection: implications for cell-based gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Microspheres for controlled release drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

A theoretical model of erosion and macromolecular drug release from biodegrading microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Controllable delivery of non-viral DNA from porous scaffolds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Delivery of plasmid DNA to articular chondrocytes via novel collagen-glycosaminoglycan matrices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Gene delivery in tissue engineering: a photopolymer platform to coencapsulate cells and plasmid DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Hyaluronan microspheres for sustained gene delivery and site-specific targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Gene therapy progress and prospects: nonviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Nonviral vectors in the new millennium: delivery barriers in gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Progress and prospects: naked DNA gene transfer and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Pharmaceutical approach to somatic gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Characterization of DNA-hyaluronan matrix for sustained gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Robust and prolonged gene expression from injectable polymeric implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Drug-releasing scaffolds fabricated from drug-loaded microspheres.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Transfection of HEK cells via DNA-loaded PLGA and P(FASA) nanospheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

DNA-polycation nanospheres as non-viral gene delivery vehicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Gene transfer by DNA-gelatin nanospheres.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Transfection of cells mediated by biodegradable polymer materials with surface-bound polyethyleneimine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Delivery and expression of pDNA embedded in collagen matrices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Materials for Non-Viral Gene Delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Quantitative analysis of synthetic gene delivery vector design properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Stability of poly(L-lysine)-complexed plasmid DNA during mechanical stress and DNase I treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Fabrication and in vitro testing of polymeric delivery system for condensed DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Biodegradable microparticles for the controlled delivery of oligonucleotides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Transfection by polyethyleneimine-coated microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Development of a calcium phosphate co-precipitate/poly(lactide-co-glycolide) DNA delivery system: release kinetics and cellular transfection studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

A triploblast origin for Myxozoa?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Coacervate microspheres as carriers of recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Cell contact dependent extended release of adenovirus by microparticles in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Improved method of recombinant AAV2 delivery for systemic targeted gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Endovascular microcoil gene delivery using immobilized anti-adenovirus antibody for vector tethering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Metabolic biotinylation of recombinant proteins in mammalian cells and in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Metabolic biotinylation of secreted and cell surface proteins from mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Engineering novel cell surface receptors for virus-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Taking Gene Therapy into the Clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Clinical development of gene therapy for colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Gene therapy for human malignant brain tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Stimulation of new bone formation by direct transfer of osteogenic plasmid genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Gene delivery to cartilage defects using coagulated bone marrow aspirate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Sustained effects of gene-activated matrices after CNS injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Gene delivery from a DNA controlled-release stent in porcine coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Building drug delivery into tissue engineering design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Microarrays of cells expressing defined cDNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Arrayed adenoviral expression libraries for functional screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Cell-biological applications of transfected-cell microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.020

10.1016/J.YMTHE.2004.03.020

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference